Isolation and Molecular Characterization of a Novel Lytic Bacteriophage That Inactivates MDR Klebsiella pneumoniae Strains

MLA

Victor M. Balcão, et al. “Isolation and Molecular Characterization of a Novel Lytic Bacteriophage That Inactivates MDR Klebsiella Pneumoniae Strains.” Pharmaceutics, vol. 14, no. 7, July 2022, p. 1421. EBSCOhost, https://doi.org/10.3390/pharmaceutics14071421.

APA

Victor M. Balcão, Fernanda C. Moreli, Erica C. Silva, Bianca G. Belline, Layla F. Martins, Fernando P. N. Rossi, Carla Pereira, Marta M. D. C. Vila, & Aline M. da Silva. (2022). Isolation and Molecular Characterization of a Novel Lytic Bacteriophage That Inactivates MDR Klebsiella pneumoniae Strains. Pharmaceutics, 14(7), 1421. https://doi.org/10.3390/pharmaceutics14071421

Chicago

Victor M. Balcão, Fernanda C. Moreli, Erica C. Silva, Bianca G. Belline, Layla F. Martins, Fernando P. N. Rossi, Carla Pereira, Marta M. D. C. Vila, and Aline M. da Silva. 2022. “Isolation and Molecular Characterization of a Novel Lytic Bacteriophage That Inactivates MDR Klebsiella Pneumoniae Strains.” Pharmaceutics 14 (7): 1421. doi:10.3390/pharmaceutics14071421.